课题基金 / 基金详情

Better chemotherapy with reduced side effects and higher cure rates - optimizing the quality of drug delivery in consideration of kidney function

Better chemotherapy with reduced side effects and higher cure rates - optimizing the quality of drug delivery in consideration of kidney function
更好的化疗,减少副作用和提高治愈率 - 考虑肾功能优化药物输送质量
批准号:
233942
负责人:
Ling Lin
金额:
$3.28万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-10-01 至 2012-10-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
除了肝脏,肾脏是消除化疗药物的第二大重要器官。然而,并不是每个癌症中心都将肾功能作为化疗剂量计算的一部分。其中一个原因是,公约a
英文摘要
Besides the liver, kidneys are the second most important organs for eliminating chemotherapy agents. However, not every cancer center considers the kidney function as part of the chemotherapy dosage calculation. One reason for this is that the conventiona
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金